SEC Form 4 · accession 0000919574-19-002297
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
BROADWOOD PARTNERS, L.P.
Director · 10% Owner
BROADWOOD CAPITAL INC
10% Owner
Neal C Bradsher
Director · 10% Owner
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1,F2 | Mar 8, 2019 | J | 3,757,430 | — | A | 33,728,991 | D | |
| Common SharesF3 | Mar 8, 2019 | J | 0 | $0.00 | A | 33,728,991 | I | See Footnote |
| Common SharesF4 | holding | — | — | — | 62,908 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities were acquired pursuant to a merger between the Issuer and Asterias Biotherapeutics, Inc. ("Asterias") that became effective on March 8, 2019 (the "Merger"). Pursuant to the Merger, each share of Asterias' common stock, $0.001 par value, was converted into the right to receive 0.71 Shares. As the holder of 5,292,156 shares of Asterias' common stock on the effective date of the Merger, Broadwood Partners received 3,757,430 Shares in the Merger. On the effective date of the Merger, the closing price of Asterias' common stock was $0.9450 per share, and the closing price of the Issuer's common shares was $1.31 per share.
- F2These securities are owned by Broadwood Partners, L.P.
- F3The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F4These securities are owned by Neal C. Bradsher in his personal capacity.